Associated Papers
Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins, 2023.
Connelly SV et al.
Medrxiv : the Preprint Server for Health Sciences, 2025
40778117 (PubMed )
Supplement: media-2.xlsx › Sheet1
A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.
Ogwang R et al.
Antimicrobial Agents and Chemotherapy, 2024
High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing.
Young NW et al.
Medrxiv : the Preprint Server for Health Sciences, 2024
Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
Madkhali AM et al.
Malaria Journal, 2020
Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
Pathak A et al.
Malaria Journal, 2020
Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
Hussien M et al.
Plos One, 2020
Nanopore sequencing of drug-resistance-associated genes in malaria parasites, Plasmodium falciparum.
Runtuwene LR et al.
Scientific Reports, 2018
29844487 (PubMed )
Supplement: 41598_2018_26334_MOESM1_ESM.docx
Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.
Boussaroque A et al.
Malaria Journal, 2016
Select a paper to view details